The natural auto-immune properties of cannabis provide a COVID-19 defense
Since the COVID-19 pandemic was declared a national emergency in March 2020, researchers have observed an increase in drug use. Marijuana was first seen as an alternative to release the stress caused by confinement at the time. Although some opponents indicate that the severity of COVID-19 could be increased by its use, studies show otherwise. According to recent research, the use of this plant has nothing to do with increased susceptibility to coronavirus.
A group of scientists associated with the David Geffen School of Medicine at the University of California, LA wanted to investigate further. They retrospectively analyzed more than 1,800 patients with COVID.
According to the report, marijuana users hospitalized because of the pandemic had better clinical outcomes compared to non-users, including less need for ICU admission or mechanical ventilation. This, on the other hand, does not mean that an association was found between cannabis use and better overall survival rates, the researchers clarified.
Throughout the study, the authors said the association between decreased symptom severity and marijuana use was solid even after adjustment for potential confounders, such as comorbid conditions, age, and gender. “While previous data have determined the detrimental relationship of tobacco smoking with COVID-19, this study suggests that cannabis may actually lead to reduced disease severity and better outcomes despite a five-fold greater concomitant use of tobacco amongst cannabis users compared to non-users in our study population,” the researchers concluded.
Since the pandemic began, several preclinical studies have been conducted that have been able to demonstrate that the use of some cannabis compounds has the effects necessary to modulate COVID infections. However, further research is still needed to corroborate that cannabinoids can help prevent COVID infections or mitigate the symptoms of the virus.